Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) EPS (Basic) (2020 - 2025)

Roivant Sciences (ROIV) has disclosed EPS (Basic) for 6 consecutive years, with -$0.38 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) fell 265.22% year-over-year to -$0.38, compared with a TTM value of -$0.64 through Dec 2025, down 109.97%, and an annual FY2025 reading of -$0.24, down 104.03% over the prior year.
  • EPS (Basic) was -$0.38 for Q4 2025 at Roivant Sciences, down from -$0.16 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $6.37 in Q4 2023 and bottomed at -$0.49 in Q4 2022.
  • Average EPS (Basic) over 5 years is $0.17, with a median of -$0.33 recorded in 2025.
  • The sharpest move saw EPS (Basic) tumbled 550.0% in 2021, then soared 1400.0% in 2023.
  • Year by year, EPS (Basic) stood at -$0.41 in 2021, then decreased by 19.51% to -$0.49 in 2022, then soared by 1400.0% to $6.37 in 2023, then plummeted by 96.39% to $0.23 in 2024, then crashed by 265.22% to -$0.38 in 2025.
  • Business Quant data shows EPS (Basic) for ROIV at -$0.38 in Q4 2025, -$0.16 in Q3 2025, and -$0.33 in Q2 2025.